Your browser doesn't support javascript.
loading
Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders.
Fokstuen, S; Makrythanasis, P; Hammar, E; Guipponi, M; Ranza, E; Varvagiannis, K; Santoni, F A; Albarca-Aguilera, M; Poleggi, M E; Couchepin, F; Brockmann, C; Mauron, A; Hurst, S A; Moret, C; Gehrig, C; Vannier, A; Bevillard, J; Araud, T; Gimelli, S; Stathaki, E; Paoloni-Giacobino, A; Bottani, A; Sloan-Béna, F; Sizonenko, L D'Amato; Mostafavi, M; Hamamy, H; Nouspikel, T; Blouin, J L; Antonarakis, S E.
Afiliação
  • Fokstuen S; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Makrythanasis P; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Hammar E; Department of Genetic Medicine and Development, University of Geneva, 1 rue Michel-Servet, 1211, Geneva, Switzerland.
  • Guipponi M; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Ranza E; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Varvagiannis K; Department of Genetic Medicine and Development, University of Geneva, 1 rue Michel-Servet, 1211, Geneva, Switzerland.
  • Santoni FA; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Albarca-Aguilera M; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Poleggi ME; Department of Genetic Medicine and Development, University of Geneva, 1 rue Michel-Servet, 1211, Geneva, Switzerland.
  • Couchepin F; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Brockmann C; Department of Genetic Medicine and Development, University of Geneva, 1 rue Michel-Servet, 1211, Geneva, Switzerland.
  • Mauron A; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Hurst SA; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Moret C; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Gehrig C; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Vannier A; Institute for Ethics, History, and the Humanities, Geneva University Medical School, Geneva, Switzerland.
  • Bevillard J; Institute for Ethics, History, and the Humanities, Geneva University Medical School, Geneva, Switzerland.
  • Araud T; Institute for Ethics, History, and the Humanities, Geneva University Medical School, Geneva, Switzerland.
  • Gimelli S; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Stathaki E; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Paoloni-Giacobino A; Department of Genetic Medicine and Development, University of Geneva, 1 rue Michel-Servet, 1211, Geneva, Switzerland.
  • Bottani A; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Sloan-Béna F; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Sizonenko LD; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Mostafavi M; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Hamamy H; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Nouspikel T; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Blouin JL; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
  • Antonarakis SE; Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland.
Hum Genomics ; 10(1): 24, 2016 06 28.
Article em En | MEDLINE | ID: mdl-27353043
ABSTRACT

BACKGROUND:

In order to optimally integrate the use of high-throughput sequencing (HTS) as a tool in clinical diagnostics of likely monogenic disorders, we have created a multidisciplinary "Genome Clinic Task Force" at the University Hospitals of Geneva, which is composed of clinical and molecular geneticists, bioinformaticians, technicians, bioethicists, and a coordinator. METHODS AND

RESULTS:

We have implemented whole exome sequencing (WES) with subsequent targeted bioinformatics analysis of gene lists for specific disorders. Clinical cases of heterogeneous Mendelian disorders that could potentially benefit from HTS are presented and discussed during the sessions of the task force. Debate concerning the interpretation of identified variants and the content of the final report constitutes a major part of the task force's work. Furthermore, issues related to bioethics, genetic counseling, quality control, and reimbursement are also addressed.

CONCLUSIONS:

This multidisciplinary task force has enabled us to create a platform for regular exchanges between all involved experts in order to deal with the multiple complex issues related to HTS in clinical practice and to continuously improve the diagnostic use of HTS. In addition, this task force was instrumental to formally approve the reimbursement of HTS for molecular diagnosis of Mendelian disorders in Switzerland.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Técnicas de Diagnóstico Molecular / Sequenciamento de Nucleotídeos em Larga Escala / Exoma / Doenças Genéticas Inatas Tipo de estudo: Diagnostic_studies / Prognostic_studies Aspecto: Ethics Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Hum Genomics Assunto da revista: GENETICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Técnicas de Diagnóstico Molecular / Sequenciamento de Nucleotídeos em Larga Escala / Exoma / Doenças Genéticas Inatas Tipo de estudo: Diagnostic_studies / Prognostic_studies Aspecto: Ethics Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Hum Genomics Assunto da revista: GENETICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suíça